Big Movers: Hertz Global Holdings (NYSE:HTZ), Google Inc (NASDAQ:GOOGL), Civeo Corporation (NYSE:CVEO), Emergent BioSolutions (NYSE:EBS), Permian Basin Royalty Trust (NYSE:PBT)


On Tuesday shares of Hertz Global Holdings, Inc. (NYSE:HTZ) closed at $21.08. Company’s sales growth for last 5 years was 4.80% and EPS growth for next 5 years is recorded as 13.00%. Hertz Global Holdings, Inc. (NYSE:HTZ) said it received notification from the New York Stock Exchange that it is out of listing compliance because of the late filing of its annual report. Following an internal audit, the Naples, Fla.-based car-rental company disclosed in June that it must restate results for 2011 and would correct and possibly restate 2012 and 2013 financial statements. That announcement followed earlier warnings that it had detected reporting errors.

Google Inc (NASDAQ:GOOGL) in last trading activity increased 2.15% to close at $577.54. Company weekly performance is 3.57% while its quarterly performance stands at 11.06%. Google Inc (NASDAQ:GOOGL) is -5.15% away from its 52 week high. Google Inc. (NASDAQ:GOOGL) announced Tuesday morning that Ruth Porat has been named its new CFO. Porat was the CFO at Morgan Stanley and will succeed Patrick Pichette.

On last trading day Civeo Corporation (NYSE:CVEO) increased 1.54% to close at $2.63. Its volatility for the week is 8.47% while volatility for the month is 6.24%. Civeo Corporation (NYSE:CVEO) monthly performance is -28.73%.

On Tuesday shares of Emergent BioSolutions, Inc. (NYSE:EBS) closed at $29.30. Company’s sales growth for last 5 years was 13.90% and EPS growth for next 5 years is recorded as 10.00%. Specialty biopharma company Emergent BioSolutions Inc. (NYSE:EBS) Wednesday said it received U.S. Food and Drug Administration approval for its Anthrasil or AIGIV, for treatment of inhalational anthrax in combination with appropriate antibacterial drugs. The company said Anthrasil is now qualified for seven years of market exclusivity and it is the only FDA-approved polyclonal therapeutic for the treatment of anthrax disease.

On last trading day Permian Basin Royalty Trust (NYSE:PBT) increased 5.06% to close at $8.10. Its volatility for the week is 4.61% while volatility for the month is 3.42%. PBT’s sales growth for past 5 years was 4.70% and its EPS growth for past 5 years was 4.70%. Permian Basin Royalty Trust (NYSE:PBT) monthly performance is -19.16%. On March 20, Permian Basin Royalty Trust (NYSE:PBT) declared a cash distribution to the holders of its units of beneficial interest of $0.021577 per unit, payable on April 14, 2015, to unit holders of record on March 31, 2015.


Leave a Reply

Your email address will not be published. Required fields are marked *